Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agents

Published:2016-12-29 Issue:2 Volume:17 Page:151-162
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Porta Camillo¹²,Toscani Ilaria¹,Czarnecka Anna M.³,Szczylik Cezary A.³

Affiliation:

1. Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy

2. Italian Group of Onco-Nephrology/Gruppo Italiano di Onco-Nefrologia (G.I.O.N.), Pavia, Italy

3. Department of Oncology, Military Institute of Medicine, Warsaw, Poland

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1271869

Reference72 articles.

1. TYROSINE KINASE INHIBITORS AND THE DAWN OF MOLECULAR CANCER THERAPEUTICS

2. Cancer Immunotherapy

3. Hallmarks of Cancer: The Next Generation

4. Mechanisms of tumor cell resistance to the current targeted-therapy agents

5. Overcoming Resistance to Targeted Therapies in Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review;Critical Reviews in Oncology/Hematology;2019-07

2. Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC-Registry;Clinical Genitourinary Cancer;2018-12

3. Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence;Therapeutic Advances in Urology;2017-06-29

4. Pharmacotherapy for treating metastatic clear cell renal cell carcinoma;Expert Opinion on Pharmacotherapy;2017-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3